Altered IL-12 signaling pathways contribute to the deficient IFN-A production by T splenocytes from tumor-bearing mice

Marta Torroella-Kouri, Lynn M. Herbert, Giselle Perry, Diana M Lopez

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

IFN-Á is a crucial cytokine produced by T and NK cells. Previous work from our laboratory has reported that in T cells of BALB/c mice bearing the D1-DMBA-3 mammary tumor, IFN-Á production is down-regulated, due to decreased expression of IL-12 by macrophages of tumor bearers. IL-12 is the main inducer of IFN-Á production in T and NK cells. To exert its function, IL-12 interacts with its receptor (IL-12R), activating a JAK/STAT signaling pathway. Our investigation suggests that there is also a deficiency in the response to IL-12 by T cells from tumor hosts. The present work reports the results of RT-PCR experiments in the study of the IL-12R expression on T cells from normal and tumor bearers. Data showed a deficient expression of the IL-12R'2 chain on T cells from tumor hosts. Gene expression arrays on IL-12-activated T cells from normal and tumor bearers confirmed the RT-PCR results, and also showed decreased expression of IL-18R in tumor bearers' T cells. Arrays also showed down-regulated expression of JAK2, STAT 1, 3, 4 and IRF-1. Finally, increased expression of SOCS 1,3,4,5 and 7, as well of Protein inhibitor of activated STATs (Pias) 1 and y was also observed in tumor bearers' T cells.

Original languageEnglish
Pages (from-to)345-354
Number of pages10
JournalCancer Genomics and Proteomics
Volume1
Issue number5-6
StatePublished - Sep 1 2004

Fingerprint

Bearings (structural)
Interleukin-12
T-cells
Tumors
T-Lymphocytes
Neoplasms
Protein Inhibitors of Activated STAT
Natural Killer Cells
9,10-Dimethyl-1,2-benzanthracene
Macrophages
Polymerase Chain Reaction
Gene expression
Interleukin-2
Cytokines

Keywords

  • Gene expression microarrays
  • IFN-Á
  • IL-12 receptor
  • Signal transduction
  • T cells
  • Tumor immunity
  • Tumor-bearing mice

ASJC Scopus subject areas

  • Genetics
  • Molecular Biology
  • Cancer Research
  • Biochemistry

Cite this

Altered IL-12 signaling pathways contribute to the deficient IFN-A production by T splenocytes from tumor-bearing mice. / Torroella-Kouri, Marta; Herbert, Lynn M.; Perry, Giselle; Lopez, Diana M.

In: Cancer Genomics and Proteomics, Vol. 1, No. 5-6, 01.09.2004, p. 345-354.

Research output: Contribution to journalArticle

@article{a06fce1717144c078cc611651fea8696,
title = "Altered IL-12 signaling pathways contribute to the deficient IFN-A production by T splenocytes from tumor-bearing mice",
abstract = "IFN-{\'A} is a crucial cytokine produced by T and NK cells. Previous work from our laboratory has reported that in T cells of BALB/c mice bearing the D1-DMBA-3 mammary tumor, IFN-{\'A} production is down-regulated, due to decreased expression of IL-12 by macrophages of tumor bearers. IL-12 is the main inducer of IFN-{\'A} production in T and NK cells. To exert its function, IL-12 interacts with its receptor (IL-12R), activating a JAK/STAT signaling pathway. Our investigation suggests that there is also a deficiency in the response to IL-12 by T cells from tumor hosts. The present work reports the results of RT-PCR experiments in the study of the IL-12R expression on T cells from normal and tumor bearers. Data showed a deficient expression of the IL-12R'2 chain on T cells from tumor hosts. Gene expression arrays on IL-12-activated T cells from normal and tumor bearers confirmed the RT-PCR results, and also showed decreased expression of IL-18R in tumor bearers' T cells. Arrays also showed down-regulated expression of JAK2, STAT 1, 3, 4 and IRF-1. Finally, increased expression of SOCS 1,3,4,5 and 7, as well of Protein inhibitor of activated STATs (Pias) 1 and y was also observed in tumor bearers' T cells.",
keywords = "Gene expression microarrays, IFN-{\'A}, IL-12 receptor, Signal transduction, T cells, Tumor immunity, Tumor-bearing mice",
author = "Marta Torroella-Kouri and Herbert, {Lynn M.} and Giselle Perry and Lopez, {Diana M}",
year = "2004",
month = "9",
day = "1",
language = "English",
volume = "1",
pages = "345--354",
journal = "Cancer Genomics and Proteomics",
issn = "1109-6535",
publisher = "International Institute of Anticancer Research",
number = "5-6",

}

TY - JOUR

T1 - Altered IL-12 signaling pathways contribute to the deficient IFN-A production by T splenocytes from tumor-bearing mice

AU - Torroella-Kouri, Marta

AU - Herbert, Lynn M.

AU - Perry, Giselle

AU - Lopez, Diana M

PY - 2004/9/1

Y1 - 2004/9/1

N2 - IFN-Á is a crucial cytokine produced by T and NK cells. Previous work from our laboratory has reported that in T cells of BALB/c mice bearing the D1-DMBA-3 mammary tumor, IFN-Á production is down-regulated, due to decreased expression of IL-12 by macrophages of tumor bearers. IL-12 is the main inducer of IFN-Á production in T and NK cells. To exert its function, IL-12 interacts with its receptor (IL-12R), activating a JAK/STAT signaling pathway. Our investigation suggests that there is also a deficiency in the response to IL-12 by T cells from tumor hosts. The present work reports the results of RT-PCR experiments in the study of the IL-12R expression on T cells from normal and tumor bearers. Data showed a deficient expression of the IL-12R'2 chain on T cells from tumor hosts. Gene expression arrays on IL-12-activated T cells from normal and tumor bearers confirmed the RT-PCR results, and also showed decreased expression of IL-18R in tumor bearers' T cells. Arrays also showed down-regulated expression of JAK2, STAT 1, 3, 4 and IRF-1. Finally, increased expression of SOCS 1,3,4,5 and 7, as well of Protein inhibitor of activated STATs (Pias) 1 and y was also observed in tumor bearers' T cells.

AB - IFN-Á is a crucial cytokine produced by T and NK cells. Previous work from our laboratory has reported that in T cells of BALB/c mice bearing the D1-DMBA-3 mammary tumor, IFN-Á production is down-regulated, due to decreased expression of IL-12 by macrophages of tumor bearers. IL-12 is the main inducer of IFN-Á production in T and NK cells. To exert its function, IL-12 interacts with its receptor (IL-12R), activating a JAK/STAT signaling pathway. Our investigation suggests that there is also a deficiency in the response to IL-12 by T cells from tumor hosts. The present work reports the results of RT-PCR experiments in the study of the IL-12R expression on T cells from normal and tumor bearers. Data showed a deficient expression of the IL-12R'2 chain on T cells from tumor hosts. Gene expression arrays on IL-12-activated T cells from normal and tumor bearers confirmed the RT-PCR results, and also showed decreased expression of IL-18R in tumor bearers' T cells. Arrays also showed down-regulated expression of JAK2, STAT 1, 3, 4 and IRF-1. Finally, increased expression of SOCS 1,3,4,5 and 7, as well of Protein inhibitor of activated STATs (Pias) 1 and y was also observed in tumor bearers' T cells.

KW - Gene expression microarrays

KW - IFN-Á

KW - IL-12 receptor

KW - Signal transduction

KW - T cells

KW - Tumor immunity

KW - Tumor-bearing mice

UR - http://www.scopus.com/inward/record.url?scp=66349126997&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66349126997&partnerID=8YFLogxK

M3 - Article

VL - 1

SP - 345

EP - 354

JO - Cancer Genomics and Proteomics

JF - Cancer Genomics and Proteomics

SN - 1109-6535

IS - 5-6

ER -